AKT1 and central nervous system cancer: AT13148, CZC24832 and rapamycin were all PI3K/AKT/mTOR inhibitors and rapamycin had been reported to suppress glioma cell growth by inhibiting PI3K‐Akt–mTOR signaling.22, 23, 24